PCA3 genes
AssigneesStichting Katholieke Universiteit, The University Medical Centre Nijmegen, The Johns Hopkins University
InventorsMarion J. G. Bussemakers, William B. Isaacs
Life of this patent
Estimating the term…
Loading patent…
AssigneesStichting Katholieke Universiteit, The University Medical Centre Nijmegen, The Johns Hopkins University
InventorsMarion J. G. Bussemakers, William B. Isaacs
Estimating the term…
The present invention relates, in general, to a prostate-specific antigen, PCA3. In particular, the present invention relates to nucleic acid molecules coding for the PCA3 protein; purified PCA3 proteins and polypeptides; recombinant nucleic acid molecules; cells containing the recombinant nucleic acid molecules; antibodies having binding affinity specifically to PCA3 proteins and polypeptides; hybridomas containing the antibodies; nucleic acid probes for the detection of nucleic acids encoding PCA3 proteins; a method of detecting nucleic acids encoding PCA3 proteins or polypeptides in a sample; kits containing nucleic acid probes or antibodies; bioassays using the nucleic acid sequence, protein or antibodies of this invention to diagnose, assess, or prognose a mammal afflicted with prostate cancer; therapeutic uses; and methods of preventing prostate cancer in an animal.
An isolated DNA molecule which is:
An isolated DNA molecule which is:
An isolated DNA molecule which is:
An isolated DNA molecule which is:
Dependencies are inferred from the claim text.